Tag Archives: IMGN

ImmunoGen Inc. (IMGN)

ImmunoGen, Inc. engages in the research and development of targeted therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies, and highly potent cell-killing agents. The company develops its products using its Targeted Antibody Payload (TAP) technology. Its product candidates include Trastuzumab emtansine (T-DM1), a Phase III clinical trial product for HER2+ breast cancer;....More>>>

News about IMGN

Scynexis: This Cash-Rich $2 Biotech Stock Is A Strong Buy Before 2018
Buying beaten down biotech stocks is a strategy I focus on, especially at the end of each year because as tax loss selling fades, it is possible to see very strong gains into the New Year. For example, last December, I wrote an article about Immunoge...Read More>>>

Mid-Afternoon Market Update: Dow Gains 90 Points; Micronet Enertec Technologies Shares Drop
Toward the end of trading Monday, the Dow traded up 0.39 percent to 23,449.06 while the NASDAQ climbed 0.12 percent to 6,790.66. The S&P also rose, gaining 0.17 percent to 2,583.31. Leading and Lagging Sectors Monday afternoon, the non-cyclical ...Read More>>>

Benzinga's Option Alert Recap From September 19
Related DLPH Earnings Scheduled For August 2, 2017 What Do Your Driving Patterns Say About You? Advertisers Want To Know Related NRG Watch These 8 Huge Call Purchases In Thursday Trade ...Read More>>>

Your Daily Pharma Scoop: Nabriva's Further Potential, Allergan's IP Gimmick, Supernus's Positive Dat
Avisol Capital Partners, managed by Drs Udaya Maiya and Ashok Dutta, is writing a daily scoop of all sorts of news, catalysts, ratings, and other actionable details for its watch list stocks (and the rest of the healthcare universe). The watch list i...Read More>>>

Why ImmunoGen, Inc. Jumped Higher Today"
What happened ImmunoGen (NASDAQ:IMGN) is up 15.6% at 3:35 p.m. EDT on no news. The stock price bump might be a carryover from yesterday's upgrade by Leerink Partners. Or maybe it's short-sellers buying to cover their shorts after yesterday's move. Or...Read More>>>